abl:	Abelson kinase (chromosome 9), part of Philadelphia translocation t(9;22) and therapy target structure for the tyrosine kinase inhibitors imatinib, nilotinib and dasatinib
AP:	Accelerated phase of CML
BC:	Blast crisis of CML
bcr-abl:	Gene or protein product of Philadelphia translocation t(9; 22)
CCyR:	Complete cytogenetic response (see Table 1 for definition)
CHR:	Complete hematological response (see Table 1 for definition)
CML:	Chronic myelogenous leukemia
CMR:	Complete molecular response (see Table 1 for definition)
CP:	Chronic phase of CML
IFN:	Interferon alpha
MCyR:	Major cytogenetic response (see Table 1 for definition)
MMR:	Major molecular response (see Table 1 for definition)
PCyR:	Partial cytogenetic response (see Table 1 for definition)
PDGFR:	Platelet-derived growth factor receptor
PFS:	Progression-free survival (no progression in AP/BC)
Ph+ ALL:	Philadelphia chromosome-positive acute lymphatic leukemia
qRT-PCR:	Quantitative real-time polymerase chain reaction